๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
DRI Healthcare Trust (TSX:DHT.UN)
Canada flag Canada ยท Delayed Price ยท Currency is CAD
18.95
-0.15 (-0.79%)
Nov 19, 2026, 4:00 PM EST

DRI Healthcare Trust Earnings Call Transcripts

Fiscal Year 2026

  • Q3 normalized cash receipts and Adjusted EBITDA each rose 9% YoY as EKTERLY proceeds funded JUVMO. Performance is ahead of 2026 expectations, with expanded deployment capacity and stronger multi-year growth aspirations.

  • M&A announcement

    A $316M upfront investment secures royalty rights in a novel Parkinson's therapy, with capped receipts and fixed payments providing downside protection. The deal is expected to drive significant EBITDA growth, enable future acquisitions, and strengthen portfolio balance.

  • Record Q2 2026 results featured 13% income growth, 40% higher adjusted EBITDA, and robust cash receipts. Monetization of Ekterly and FDA approval of Lumvoa highlight portfolio strength, while strong liquidity supports continued buybacks and new investments.

  • AGM 2026

    The meeting confirmed quorum, elected eight trustees, and approved all motions including auditor reappointment, a carried interest plan, and a unit increase amendment. Record operating results and strategic financial initiatives were highlighted, with a focus on growth and innovation in 2026.

  • Q1 2026 saw record income and EBITDA margin, driven by strong royalty growth and disciplined expense management. Balance sheet strength improved via debt refinancing, while portfolio assets like ORSERDU and EKTERLY outperformed. Royalty market growth and capital flexibility support a positive outlook.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021